Legato Capital Management LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1442641 San Francisco, CA

Position in AXSM

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,626,232

+$867,957 QoQ

Shares Held

15,538

+61.4% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

11 quarters on record

Healthcare · as of Mar 31, 2026

Legato Capital Management LLC holds $66,578,999 across 48 Biotechnology names. AXSM ranks #7 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	39,554	$6,467,870
2	REGN	Regeneron Pharmaceuticals, Inc.	6,004	$4,638,930
3	LGND	Ligand Pharmaceuticals Inc	22,378	$4,467,767
4	BBIO	BridgeBio Pharma, Inc.	56,326	$4,182,768
5	MIRM	Mirum Pharmaceuticals, Inc.	41,763	$3,858,065
6	RVMD	Revolution Medicines, Inc.	37,394	$3,636,566
7	AXSM	Axsome Therapeutics, Inc. This page	15,538	$2,626,232
8	APGE	Apogee Therapeutics, Inc.	29,968	$2,522,406

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,626,232	15,538	+61.4%	Shares	Other	2026-05-14
2025-12-31	$1,758,275	9,627	+90.6%	Shares	Other	2026-02-06
2025-09-30	$613,443	5,051	+17.4%	Shares	Other	2025-11-12
2025-06-30	$448,981	4,301	-56.9%	Shares	Other	2025-08-14
2025-03-31	$1,164,084	9,981	+110.9%	Shares	Other	2025-05-06
2024-03-31	$377,693	4,733	-45.1%	Shares	Other	2024-04-15
2023-12-31	$686,224	8,622	0.0%	Shares	Other	2024-01-16
2023-09-30	$602,591	8,622	-27.9%	Shares	Other	2023-10-12
2023-06-30	$858,870	11,952	+70.1%	Shares	Other	2023-08-18
2023-03-31	$433,425	7,027	0.0%	Shares	Other	2023-05-25
2022-12-31	$541,992	7,027	—	Shares	Other	2023-02-01
No filing history on record for this holder in this stock.